Plasma Chromogranin B as a Marker of Tumor Burden and Radiological Progression in Neuroendocrine Tumors

被引：0
|
作者：
Braude, D. [1 ]
Bartholomew, T. K. [1 ]
Rossi, R. E. [1 ]
Garcia-Hernandez, A. [1 ]
Mullan, M. [1 ]
Caplin, M. [1 ]
Toumpanakis, C. [1 ]
机构：
[1] Royal Free Hosp, ENETS Ctr Excellence, Neuroendocrine Tumour Unit, London NW3 2QG, England
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
chromogranin b; midgut nets; pancreatic net; progression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H3
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [21] IMMUNOHISTOCHEMICAL DEMONSTRATION OF CHROMOGRANIN-A AND CHROMOGRANIN-B IN NEUROENDOCRINE TUMORS OF THE LUNG
    TOTSCH, M
    MULLER, LC
    HITTMAIR, A
    OFNER, D
    GIBBS, AR
    SCHMID, KW
    HUMAN PATHOLOGY, 1992, 23 (03) : 312 - 316
  • [22] Clinical usefulness of plasma chromogranin A in pancreatic neuroendocrine tumor
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Yoon, Yong Bum
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 362 - 362
  • [23] Plasma Chromogranin A Levels Predict Survival and Tumor Response in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Chou, Wen-Chi
    Chen, Jen-Shi
    Hung, Yu-Shin
    Hsu, Jun-Te
    Chen, Tse-Ching
    Sun, Chien-Feng
    Lu, Chang-Hsien
    Hwang, Tsann-Long
    ANTICANCER RESEARCH, 2014, 34 (10) : 5661 - 5669
  • [24] Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors
    Hijioka, Masayuki
    Ito, Tetsuhide
    Igarashi, Hisato
    Fujimori, Nao
    Lee, Lingaku
    Nakamura, Taichi
    Jensen, Robert T.
    Takayanagi, Ryoichi
    CANCER SCIENCE, 2014, 105 (11) : 1464 - 1471
  • [25] Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors
    Miki, Masami
    Ito, Tetsuhide
    Hijioka, Masayuki
    Lee, Lingaku
    Yasunaga, Kohei
    Ueda, Keijiro
    Fujiyama, Takashi
    Tachibana, Yuichi
    Kawabe, Ken
    Jensen, Robert T.
    Ogawa, Yoshihiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (06) : 520 - 528
  • [26] Cromanet: Observation study to evaluate plasma chromogranin a (CrA) as a marker for the diagnosis and follow up of neuroendocrine tumors (NETs)
    Dogliotti, L.
    De Braud, F.
    Delle Fave, G.
    Uberti, E. Degli
    Gion, M.
    Tomassetti, P.
    ANNALS OF ONCOLOGY, 2005, 16 : 51 - 51
  • [27] Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Tian, Tiantian
    Gao, Jing
    Li, Na
    Li, Yanyan
    Lu, Ming
    Li, Zhongwu
    Lu, Zhihao
    Li, Jie
    Shen, Lin
    PLOS ONE, 2016, 11 (05):
  • [28] Is Ghrelin a potential tumor marker in neuroendocrine tumors?
    Marino, M.
    Grimaldi, F.
    Berretti, D.
    Tonutti, E.
    Visentini, D.
    Trianni, A.
    Zilli, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 : 15 - 15
  • [29] Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum
    Woltering, Eugene A.
    Beyer, David T.
    Thiagarajan, Ramcharan
    Ramirez, Robert A.
    Wang, Yi-Zarn
    Ricks, M. Jennifer
    Boudreaux, J. Philip
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 222 (04) : 534 - 542
  • [30] Angiogenesis and Tumor Progression in Neuroendocrine Digestive Tumors
    Poncet, Gilles
    Villaume, Karine
    Walter, Thomas
    Pourreyron, Celine
    Theillaumas, Aurelie
    Lepinasse, Florian
    Hervieu, Valerie
    Cordier-Bussat, Martine
    Scoazec, Jean-Yves
    Roche, Colette
    JOURNAL OF SURGICAL RESEARCH, 2009, 154 (01) : 68 - 77
12345